RxDoctor Payments Data

Charles Catania, MD

Family Medicine · West Chester, PANPI 1609037027

Payments from drug & device makers

$8,109in general payments, 2019–2025

Across 486 payments — averaging $16.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Novo Nordisk$777
  • Pfizer$775
  • AstraZeneca$705
  • Boehringer Ingelheim$452
  • GSK$401
  • plus $4K from 54 others

What the payments were for

  • Food & beverage$8,072100%
  • Education$370%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)88$1,282
Novo Nordisk49$777
Pfizer58$775
AstraZeneca(2 entities)43$705
Boehringer Ingelheim24$452
GSK23$401
Lilly USA, LLC19$329
Astellas Pharma US Inc11$234
Sanofi-aventis U.S. LLC12$205
Abbott7$166
Teva Pharmaceuticals USA, Inc.8$157
Corium, LLC12$146
Merck10$138
Otsuka America Pharmaceutical, Inc.8$136
Lundbeck LLC6$124
E.r. Squibb & Sons, L.L.C.5$111
Kowa Pharmaceuticals America, Inc.8$108
Exact Sciences4$107
Dexcom, Inc.3$92
Bayer5$92
Phathom Pharmaceuticals, Inc.4$91
Ironshore Pharmaceuticals Inc.5$80
Amgen5$76
Novartis4$72
IBSA Pharma Inc.3$64
Inspire Medical Systems, Inc.3$62
Amarin Pharma, Inc.3$62
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC4$60
Shield Therapeutics Inc1$55
Takeda Pharmaceuticals U.S.A., Inc.5$53
Johnson & Johnson3$51
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)2$50
Xeris Pharmaceuticals, Inc.2$47
Almatica Pharma LLC2$46
Stryker1$45
Jazz Pharmaceuticals Inc.2$45
Neurocrine Biosciences, Inc.2$44
Quidel Corporation1$40
Axsome Therapeutics, Inc.2$39
Ferring Pharmaceuticals Inc.2$38
Arbor Pharmaceuticals, Inc.2$34
Adlon Therapeutics L.p.2$31
Medtronic1$31
Bausch Health US, LLC2$29
Biohaven Pharmaceutical Holding Company Ltd.1$22
Sunovion Pharmaceuticals Inc.1$21
Philips North America LLC1$21
Medicomp Inc1$20
Antares Pharma, Inc.1$20
Amneal Pharmaceuticals LLC1$19
Tolmar, Inc.1$18
Esperion Therapeutics, Inc.1$18
Mirum Pharmaceuticals, Inc.1$18
Biogen1$17
Sanofi Pasteur Inc.1$17
Supernus Pharmaceuticals, Inc.1$17
Currax Pharmaceuticals LLC1$16
Hologic Sales And Service, LLC1$16
Dermira, Inc.1$16
Tris Pharma Inc1$14

How this compares

$8,109 in reported general payments places this provider in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

See all family medicine providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$192,983
Medicare patients
607
Services billed
4,544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin120$177,888
EliquisApixaban121$128,350
OzempicSemaglutide72$72,157
XareltoRivaroxaban54$54,163
JanumetSitagliptin Phos/Metformin Hcl41$48,597
JanuviaSitagliptin Phosphate25$37,159
MounjaroTirzepatide24$25,807
FarxigaDapagliflozin Propanediol17$25,615
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$25,041
TrulicityDulaglutide17$24,918
TradjentaLinagliptin13$20,127
MyrbetriqMirabegron17$18,823
ViberziEluxadoline12$17,450
LinzessLinaclotide12$13,834
Breo ElliptaFluticasone/Vilanterol24$12,527

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$452$198,015133 claims
PfizerEliquis$775$128,350121 claims
MerckJanumet, Januvia$138$85,75666 claims
Novo NordiskOzempic$777$72,15772 claims
Johnson & JohnsonXarelto, Invokana$51$63,97868 claims
Lilly USA, LLCMounjaro, Trulicity$329$50,72641 claims
GSKTrelegy Ellipta, Breo Ellipta$401$37,56847 claims
AbbVieViberzi, Linzess, Synthroid$1,282$34,94671 claims
AstraZenecaFarxiga, Symbicort$705$29,88129 claims
Astellas Pharma US IncMyrbetriq$234$18,82317 claims
Sanofi-aventis U.S. LLCSoliqua 100-33$205$11,67613 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$19$3,325233 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,967 family medicine providers in Pennsylvania.

Other family medicine in West Chester

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →